Cargando…
Phenylethyl isothiocyanate reverses cisplatin resistance in biliary tract cancer cells via glutathionylation-dependent degradation of Mcl-1
Biliary tract cancer (BTC) is a highly malignant cancer. BTC exhibits a low response rate to cisplatin (CDDP) treatment, and therefore, an understanding of the mechanism of CDDP resistance is urgently needed. Here, we show that BTC cells develop CDDP resistance due, in part, to upregulation of myelo...
Autores principales: | Li, Qiwei, Zhan, Ming, Chen, Wei, Zhao, Benpeng, Yang, Kai, Yang, Jie, Yi, Jing, Huang, Qihong, Mohan, Man, Hou, Zhaoyuan, Wang, Jian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4891119/ https://www.ncbi.nlm.nih.gov/pubmed/26848531 http://dx.doi.org/10.18632/oncotarget.7171 |
Ejemplares similares
-
Phenylethyl Isothiocyanate: A Bioactive Agent for Gastrointestinal Health
por: Coscueta, Ezequiel R., et al.
Publicado: (2022) -
FXR agonists enhance the sensitivity of biliary tract cancer cells to cisplatin via SHP dependent inhibition of Bcl-xL expression
por: Wang, Wei, et al.
Publicado: (2016) -
Chitosan-olive oil microparticles for phenylethyl isothiocyanate delivery: Optimal formulation
por: Coscueta, Ezequiel R., et al.
Publicado: (2021) -
Phenylethyl Isothiocyanate Extracted from Watercress By-Products with Aqueous Micellar Systems: Development and Optimisation
por: Coscueta, Ezequiel R., et al.
Publicado: (2020) -
Allyl-, Butyl- and Phenylethyl-Isothiocyanate Modulate Akt–mTOR and Cyclin–CDK Signaling in Gemcitabine- and Cisplatin-Resistant Bladder Cancer Cell Lines
por: Rutz, Jochen, et al.
Publicado: (2022)